Search
Search
About
Log in
Join
Experiences with
Relugolix
Posts
Communities
70 public posts
Filter results
FDA) today approved relugolix (Orgovyx) for the treatment of adult patients with advanced prostate cancer.
https://www.medscape.com/viewarticle/942933?nlid=138790_3901&src=wnl_newsalrt_201218_MSCPEDIT&uac=399617CV&impID=2746365&faf=1
https://www.medscape.com/viewarticle/942933?nlid=138790_3901&src=wnl_newsalrt_201218_MSCPEDIT&uac=399617CV&impID=2746365&faf=1
mrssnappy
in
Advanced Prostate Cancer
3 years ago
Please guide on Medical oncologist's advice
Would also like to know about
relugolix
. Sorry for too many questions
Would also like to know about
relugolix
. Sorry for too many questions
Nirman
in
Advanced Prostate Cancer
4 years ago
NO MORE SHOTS (SOON) Urologist won't be happy!! bye bye lupron
https://www.onclive.com/view/fda-grants-priority-review-to-
relugolix
-for-advanced-prostate-cancer?eKey=ZGd3aXpAbGV3aXMtYXF1YXRlY2guY29t
https://www.onclive.com/view/fda-grants-priority-review-to-
relugolix
-for-advanced-prostate-cancer?eKey=ZGd3aXpAbGV3aXMtYXF1YXRlY2guY29t
Longterm101
in
Advanced Prostate Cancer
4 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Relugolix versus Leuprolide - Neal Shore video.
The difference of 7.9 percentage points (95% CI, 4.1 to 11.8) showed noninferiority and superiority of
relugolix
(P<0.001 for superiority). All other key secondary end points showed superiority of
relugolix
over leuprolide (P<0.001).
The difference of 7.9 percentage points (95% CI, 4.1 to 11.8) showed noninferiority and superiority of
relugolix
(P<0.001 for superiority). All other key secondary end points showed superiority of
relugolix
over leuprolide (P<0.001).
pjoshea13
in
Advanced Prostate Cancer
4 years ago
Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer The New England Journal of Medicine
Sustained castrate-level testosterone suppression (primary endpoint) was superior with
relugolix
(97% vs 89% through 48 weeks). In addition, cardiovascular event risk was lower with
relugolix
.
Sustained castrate-level testosterone suppression (primary endpoint) was superior with
relugolix
(97% vs 89% through 48 weeks). In addition, cardiovascular event risk was lower with
relugolix
.
Balsam01
in
Advanced Prostate Cancer
4 years ago
relugolix ADT
https://www.onclive.com/web-exclusives/fda-approval-sought-for-
relugolix
-in-prostate-cancer#:~:text=A%20New%20Drug%20Application%20(NDA,the%20oral%20GnRH%20receptor%20antagonist.
https://www.onclive.com/web-exclusives/fda-approval-sought-for-
relugolix
-in-prostate-cancer#:~:text=A%20New%20Drug%20Application%20(NDA,the%20oral%20GnRH%20receptor%20antagonist.
spencoid2
in
Prostate Cancer And Gay Men
4 years ago
Relugolix, a pill alternative to Lupron shows strong trial results
and most importantly, stopping the therapy leads to a strong rebound of testosterone levels for many men, when compared to Lupron: https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-additional-positive-efficacy-and
and most importantly, stopping the therapy leads to a strong rebound of testosterone levels for many men, when compared to Lupron: https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-additional-positive-efficacy-and
curious-mind1
in
Advanced Prostate Cancer
4 years ago
Resetting the Bar of Castration Resistance - Understanding Androgen Dynamics in Therapy Resistance and Treatment Choice in PCa
Oral
Relugolix
for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020;382:2187-2196. 96. Lowrance WT, Murad MH, Oh WK, Jarrard DF, Resnick MJ, Cookson MS. Castration- Resistant Prostate Cancer: AUA Guideline Amendment 2018. J Urol. 2018;200:1264- 1272. 97.
Oral
Relugolix
for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020;382:2187-2196. 96. Lowrance WT, Murad MH, Oh WK, Jarrard DF, Resnick MJ, Cookson MS. Castration- Resistant Prostate Cancer: AUA Guideline Amendment 2018. J Urol. 2018;200:1264- 1272. 97.
pjoshea13
in
Advanced Prostate Cancer
3 years ago
Relugolix. Could It Be A Game-changing Drug for Advance Prostate Cancer
What is know about this drug whose manufacturer is now seeking FDA approval after completing clinical trials? Will it replace leuprolide? Or become a viable option in addition?
What is know about this drug whose manufacturer is now seeking FDA approval after completing clinical trials? Will it replace leuprolide? Or become a viable option in addition?
ronton2
in
Advanced Prostate Cancer
4 years ago
Have you had a bad experience with lupron or something to to put your body into a chemical menopause?
I run a group called lupron warriors on facebook please message me if you have had or are thinking of having lupron also known as zoladex, prostap, gonapeptyl,
relugolix
or anything that will put your body into a chemical menopause . It has ruined my life I'm now disabled.
I run a group called lupron warriors on facebook please message me if you have had or are thinking of having lupron also known as zoladex, prostap, gonapeptyl,
relugolix
or anything that will put your body into a chemical menopause . It has ruined my life I'm now disabled.
chezzle01
in
Endometriosis UK
6 years ago
1
...
3
4
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
59 results
Endometriosis UK
3 results
Fight Prostate Cancer
3 results
View top 10 communities
Sort by
Most Relevant
Newest